This is predominantly due to the important role that the Aβ1–42/Aβ1–40 ratio (Aβ1–42/1–40) plays in supporting a diagnosis of AD, as highlighted by the amyloid, tau, neurodegeneration, or AT(N), diagnostic criteria for AD (Jack et al., 2016, 2018). Here, MAPT is linked to Alzheimer disease.